Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

arch biopartners

POPULAR ARTICLES

Arch Biopartners Receives Approval to Perform Phase I Clincial Trial for Metablok in Australia

Arch Biopartners Provides Toxicology Update for Metablok

Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients

LATEST ARTICLES

Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569

Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio

Arch Biopartners Announces Non Brokered Private Placement Financing

Arch Biopartners Provides Update on AB569 Progress

Arch Biopartners Increases Non-Brokered Private Placement

Arch Biopartners Closes Private Placement Financing

Arch Biopartners Provides Update on GMP Manufacturing of AB569

An Introduction to TSXV Life Science Stocks

An Introduction to TSXV Life Science Stocks

Pharmaceutical Investing

Arch's Anti-Bacterial Candidate to Enter Phase I Trial

Latest News

Ni-Co Energy: Advancing a Strategic Nickel-Copper-Cobalt Project in Quebec

Blue Lagoon Resources: Summer 2025 Production-ready Gold Producer in British Columbia

Ramp Metals Provides Drill and Geophysics Update

Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor

Osisko Metals Intersects 300 Metres Averaging 0.39% Copper at Gaspé Copper Project